Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SAR exploration for 4-aminotetrahydroquinazolines with adamantyl moiety against orthoflaviviruses.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

Ensemble docking based virtual screening of SARS-CoV-2 main protease inhibitors.

Molecular informatics·2024
Same author

Phenotypic assessment of antiviral activity for spiro-annulated oxepanes and azepenes.

Chemical biology & drug design·2024
Same author

The structure of inactivated mature tick-borne encephalitis virus at 3.0 Å resolution.

Emerging microbes & infections·2024
Same author

Preparation and characterization of inactivated tick-borne encephalitis virus samples for single-particle imaging at the European XFEL.

Acta crystallographica. Section D, Structural biology·2024
Same author

Elongation of N<sup>6</sup>-benzyladenosine scaffold via Pd-catalyzed C-C bond formation leads to derivatives with antiflaviviral activity.

Bioorganic & medicinal chemistry·2023

Related Experiment Video

Updated: Jul 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Two faces of drug repurposing data in machine learning-driven structure-based virtual screening supported by

Anastasia D Fomina1, Dmitry I Osolodkin2,3

  • 1Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, 108819, Russia.

Journal of Computer-Aided Molecular Design
|July 6, 2026
PubMed
Summary

Machine learning models for SARS-CoV-2 main protease (Mpro) inhibitors perform poorly with drug repurposing data alone. Combining repurposing data with specific inhibitors improves model performance and applicability in drug discovery.

Keywords:
Ensemble dockingInteraction fingerprintsMachine learningProtease inhibitorsSARS-CoV-2 main proteaseVirtual screening

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Jul 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Machine Learning

Background:

  • Ensemble docking generates protein-ligand complex structures for analysis.
  • Machine learning models are increasingly used in drug discovery.
  • The source and composition of training data significantly impact model performance.

Purpose of the Study:

  • To evaluate the impact of different inhibitor libraries on the predictive performance of random forest models for SARS-CoV-2 main protease (Mpro) inhibitors.
  • To assess the utility of drug repurposing data in machine learning models for Mpro inhibitor classification.

Main Methods:

  • Utilized random forest models for classification tasks.
  • Trained models on three distinct inhibitor libraries: drug repurposing data and rationally designed Mpro inhibitors.
  • Employed interaction fingerprints for structural analysis within a machine learning framework.

Main Results:

  • Models trained solely on drug repurposing data exhibited low predictive performance.
  • Integrating drug repurposing data with specific Mpro inhibitors substantially enhanced model applicability domains.
  • Dataset composition is crucial for successful machine learning applications in medicinal chemistry.

Conclusions:

  • Balanced dataset preparation is essential for machine learning in medicinal chemistry.
  • Drug repurposing data can be valuable when combined with targeted compound libraries.
  • The findings underscore the importance of data provenance in developing predictive models for drug discovery.